Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Santhera Regains U.S., Canadian Rights to Fipamezole in 2011

Oct. 25 (Bloomberg) -- Santhera Pharmaceuticals Holding will regain U.S. and Canadian rights to the fipamezole medicine from Biovail Laboratories as of January 2011, the company said in a statement today.

Link to Statement:{NSN LATXZ93PWT1C <GO>}

Link to Company News:{SANN SW <Equity> CN <GO>}

To contact the editor responsible for this story: Carey Sargent at csargent3@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.